Catalent blames Bloomington operation for productivity issues, stock falls 26%
Catalent Inc., a contract drug manufacturer, said Monday it would delay quarterly earnings, blaming “productivity issues and higher-than-expected costs” at three plants—including an operation in Bloomington that it bought from medical device maker Cook Group.